NR0B2 and bone cancer: Conditional KO (35) of SHP-1 in DRG nociceptors (NaV1.8-Cre Shp-1fl/fl) robustly blocked antihyperalgesia and antiallodynia of PD-L1 in bone cancer mice (Figure 6).